MARKET

LRMR

LRMR

Larimar Therapeutics Inc
NASDAQ
3.950
-0.410
-9.40%
After Hours: 3.950 0 0.00% 18:06 09/29 EDT
OPEN
4.360
PREV CLOSE
4.360
HIGH
4.360
LOW
3.870
VOLUME
139.51K
TURNOVER
0
52 WEEK HIGH
6.85
52 WEEK LOW
2.580
MARKET CAP
170.95M
P/E (TTM)
-4.2597
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at LRMR last week (0918-0922)?
Weekly Report · 4d ago
Weekly Report: what happened at LRMR last week (0911-0915)?
Weekly Report · 09/18 12:15
Weekly Report: what happened at LRMR last week (0904-0908)?
Weekly Report · 09/11 12:13
Weekly Report: what happened at LRMR last week (0828-0901)?
Weekly Report · 09/05 10:04
Weekly Report: what happened at LRMR last week (0821-0825)?
Weekly Report · 08/28 12:22
Larimar Therapeutics Inc: Statement of acquisition of beneficial ownership by individuals
Press release · 08/20 15:13
JMP Securities Reiterates Larimar Therapeutics (LRMR) Market Outperform Recommendation
NASDAQ · 08/15 22:55
JMP Securities Reiterates Market Outperform on Larimar Therapeutics, Maintains $17 Price Target
Benzinga · 08/15 14:15
More
About LRMR
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases using its cell penetrating peptide (CPP) technology platform. The Company’s lead compound, CTI-1601, is being developed as a potential treatment for Friedreichs ataxia (FA). CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with FA. FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient frataxin (FXN) due to a genetic abnormality. It also focuses on using its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. Its CPP platform enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets.

Webull offers kinds of Larimar Therapeutics Inc stock information, including NASDAQ:LRMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LRMR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LRMR stock methods without spending real money on the virtual paper trading platform.